DIRS.INFO The most relevant business & tech news

☆ Final Trades: West Pharma, Sonos, Thermo Fisher and TransDigm
▼ + stars: | 2024-02-07 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trades: West Pharma, Sonos, Thermo Fisher and TransDigmToday’s “Halftime Report” Investment Committee, Steve Weiss, Joe Terranova, Brian Belski and Karen Firestone give their top picks to watch for the second half.

Persons: Today’s, Steve Weiss, Joe Terranova, Brian Belski, Karen Firestone Organizations: West Pharma, Investment

☆ How Novo Nordisk makes its weight-loss drug Wegovy
▼ + stars: | 2023-11-01 | by ( Maggie Fick | ) www.reuters.com time to read: +3 min

[1/2] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August31, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing RightsLONDON, Nov 1 (Reuters) - Novo Nordisk (NOVOb.CO) is spending billions of dollars to boost output and ease shortages of its hugely popular, highly effective weight-loss medicine Wegovy. FILL-FINISHNovo has hired Catalent (CTLT.N), a large U.S. contract drug manufacturer, to fill injection pens for Wegovy at two of that company's plants: in Brussels and in Bloomington, Indiana. Novo has also hired another U.S. firm, Thermo Fisher (TMO.N), as a Wegovy pen filler. COMPONENTSThe Wegovy injection pens for the U.S. market slightly differ from those sold in the European markets including Norway, Denmark, Germany and UK, where it has so far launched.

Persons: Victoria Klesty, Catalent, Novo, Wegovy, Maggie Fick, Josephine Mason, Tomasz Janowski Organizations: REUTERS, Novo Nordisk, U.S, Novo, Reuters, PCI Pharma Services, autoinjectors, West Pharmaceutical Services, Stevenato, SCHOTT Pharma, Thomson Locations: Oslo, Norway, August31, Victoria, Danish, Novo, Denmark, U.S, Brussels, Bloomington , Indiana, Greenville , North Carolina, Greenville, Germany, Europe, Swiss

☆ The Israel-Hamas war is affecting the financial outlooks of these large companies
▼ + stars: | 2023-10-28 | by ( Alex Harring | ) www.cnbc.com time to read: +6 min

Aris Messinis | AFP | Getty ImagesSome of the world's most well-known companies are already seeing the Israel-Hamas war weighing on operations. On Oct. 7, militant group Hamas struck Israeli towns in a surprise attack and took more than 200 hostages. Corporations that do business or have operations in the region have already begun seeing the war change their financial outlooks as the unrest weighs on everything from advertising dollars to tourism to supply chains. Technology companies were among those seeing the conflict affect the workforce, advertising spending and supply chains. Snap said in its latest earnings release that it saw pauses in spending from a "large number of primarily brand-oriented advertising campaigns" immediately after the war began.

Persons: Aris Messinis, Scott Kirby, El Al, Jason Liberty, Liberty, we're, Susan Li, Li, We've, John Morici Organizations: Hamas, AFP, Getty, Israeli Defense Forces, Corporations, United Airlines, Delta Air Lines, American Airlines, Boeing, Royal, Israel, El Al Airlines, Nurphoto, U.S . Department of State, Technology, Facebook, West Pharmaceutical Locations: Haifa, Cyprus, Israel, Palestinian, Gaza, Tel Aviv, Royal Caribbean, Ukraine

Smurfit Kappa and WestRock will join to create a global packaging company with a value of almost $20 billion. WestRock shareholders will receive $5 in cash and one share in the new company, called Smurfit WestRock, for each WestRock share that they own. Smurfit Kappa stockholders will receive one share in the new company for each Smurfit Kappa share. Smurfit WestRock will be incorporated and domiciled in Ireland, with global headquarters in Dublin, Ireland, where Smurfit Kappa is based. Irial Finan, the chairman at Smurfit Kappa, will be chair of the company and Ken Bowles, chief financial officer at Smurfit Kappa, will serve as CFO of Smurfit WestRock.

Persons: WestRock, Smurfit, Tony Smurfit, Irial Finan, Ken Bowles, Smurfit WestRock Organizations: Kappa, West Pharmaceutical, Smurfit Kappa, Smurfit, European Union, New York Stock Exchange Locations: Europe, U.S, Brazil, Mexico, Ireland, Dublin, Atlanta

☆ Hedge fund run by T. Rowe Price's former star manager adds to bets in health care, industrials
▼ + stars: | 2023-08-17 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

A fast-growing hedge fund tacked toward health care and industrial stocks during the second quarter, according to securities filings released this week. Durable Capital Partners is a relatively new firm by Henry Ellenbogen, who helmed T. Rowe Price's New Horizons fund for most of the last decade. In the second quarter, the fund added to several health care and industrial stocks, according to security filings and data compiled by Verity's InsiderScore. On the industrials side, Durable increased its stakes in JB Hunt Transportation and RBC Bearings by 27.3% and 10.2%, respectively, according to Verity and securities filings. Since the second quarter ended on June 30, Durable Capital has disclosed three more groups of transactions.

Persons: Henry Ellenbogen, Rowe, Morningstar, Ellenbogen, Verity's, Verity Organizations: Partners, West Pharmaceutical Services, Molina Healthcare, Privia, JB, Transportation, RBC, Intuit, FirstService Corp, SS, C Technologies Locations: West, MSCI, Duolingo

☆ Stocks making the biggest moves midday: Virgin Galactic, iRobot, Cava, SoFi and more
▼ + stars: | 2023-06-16 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

iRobot — The stock surged 19% after U.K. regulators approved Amazon's $1.7 billion acquisition of the Roomba vacuum cleaner maker. Cava Group — Cava Group shares dropped 15% during trading Friday, giving back some of its gains from its massive debut Thursday on the New York Stock Exchange. SoFi Technologies — The financial technology stock dropped more than 8% after both Bank of America and Piper Sandler downgraded it to neutral from buy, citing SoFi's recent run higher. Micron Technology — Shares dipped 1.5% after Micron Technology said a China chip ban could hurt the company. Truist Financial — Shares fell 1.6% after Odeon Capital Group downgraded Truist Financial to hold from buy, according to FactSet.

Persons: Richard Branson, iRobot, Piper Sandler, Refinitiv, Morgan Stanley, Joseph Moore, — CNBC's Michelle Fox, Alex Harring, Yun Li Organizations: Virgin Galactic —, West Pharmaceutical Services, Bank of America, — Cava, New York Stock Exchange, Technologies, Adobe, Nvidia, Devices, Micron Technology, U.S . Securities, Exchange Commission, — Humana, Odeon Capital Locations: China

☆ Here are Friday's biggest analyst calls: SoFi Technologies, AutoZone, Nvidia, Meta and more
▼ + stars: | 2023-06-16 | by ( Sarah Min | ) www.cnbc.com time to read: +6 min

Bank of America downgrades SoFi Technologies to neutral from buy The downgrade follows SoFi' s recent rally. Our C$51 Price Target is 39% above the current stock price and we see close to 3:1 upside/downside skew." UBS upgrades AutoZone to buy from neutral Analyst Michael Lasser raised the price target to $2,900 from $2,800. Wells Fargo initiates Neogen Corporation at overweight and $22 price target Wells Fargo said it liked the company's improving margins. Wells Fargo initiates Bio-Rad Laboratories Inc. at overweight and $550 price target Wells said Bio-Rad's valuation is attractive at current levels.

Persons: Jefferies, John Hecht, LendingClub, Morgan Stanley, Mauricio Serna, Aritzia, Michael Lasser, Carvana, it's, Wells, Ph3, Wells Fargo, Piper Sandler, TD Cowen downgrades, LOE, Michael Bloom Organizations: . Bank of America, Technologies, Nvidia, Bank of America, UBS, West Pharmaceutical Services, Stevanato, MorphoSys, Neogen, Rad Laboratories Inc, SoFi Technologies, Health Companies Locations: EBITDA, 4Q23, BLCO

☆ These S&P 500 stocks crushed it in the first quarter. Here's where analysts see them going
▼ + stars: | 2023-04-02 | by ( Fred Imbert | ) www.cnbc.com time to read: +4 min

The S & P 500 just wrapped up a wild first quarter with surprisingly strong results. The tech and communication services sectors powered the S & P 500 higher, rising more than 20% each. Here are the 10 best S & P 500 stocks for the first quarter, and where analysts see them going based on the implied upside (or downside) to their average price targets. Nvidia led the way higher among S & P 500 stocks, surging 90.1%. As for Catalent, analysts see the stock rallying 24.5% after surging 46% in the first quarter.

☆ This week's best performers include Paramount Global and a little-known pharma stock
▼ + stars: | 2023-02-17 | by ( Fred Imbert | ) www.cnbc.com time to read: +2 min

The average price target on West Pharmaceuticals implies downside of 7.2% over the next 12 months, and only one-third of analysts rate the stock as buy. Paramount Global also popped this week, gaining around 9% after the media giant said it would increase subscription prices for its Paramount+ streaming service . Just 21% rate it as buy, and the average price target implies downside of 13%. Three-quarters of analysts covering the pet medication maker rate it as buy, with the average analyst price target implying upside of 25.3%. Canaccord Genuity upgraded the stock on the back of those results, noting it has 30% upside from here.

☆ Stocks making the biggest moves midday: Twilio, Tripadvisor, Boston Beer, Roku and more
▼ + stars: | 2023-02-16 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

Twilio — Shares jumped 19% after Twilio beat revenue expectations in its most recent quarter. Otherwise, Shopify beat expectations on the top and bottom lines. The digital communications stock reported earnings of 88 cents per share on revenue of $13.59 billion. Hasbro — Hasbro rose more than 2% after the toymaker beat earnings per share expectations. Otherwise, the firm beat earnings expectations in its latest quarter, while revenue came in line with estimates.

☆ Stocks making the biggest premarket moves: Shake Shack, Virgin Galactic, Paramount and more
▼ + stars: | 2023-02-16 | by ( Michelle Fox | ) www.cnbc.com time to read: +4 min

Analysts surveyed by Refinitiv were expecting earnings of 23 cents per share on $8.16 billion of revenue. Excluding items, it earned 88 cents per share, slightly above the Refinitiv estimate of 86 cents per share. Cisco also beat revenue expectations. Twilio — The communications tools maker rose nearly 9% after reporting revenue of $1.02 billion, above the $1 billion analyst polled by Refinitiv expected. West Pharmaceutical Services — The drug and health-care products manufacturer gained 5.3% after reporting a fourth-quarter earnings and revenue beat.

☆ Morning Bid: Growth trumps rates
▼ + stars: | 2023-02-16 | by ( ) www.reuters.com time to read: +6 min

While there were some questions about seasonal adjustments in the data, economists were impressed that sales growth was pretty broad based and have scrambled to re-crunch first quarter U.S. output forecasts as a result. There may be a more mixed picture from Thursday's data slate on producer prices, housing starts and weekly jobless claims. Even though rates futures and Treasury yields ticked back a bit today, pricing now has Fed policy rates moving as high as 5.25% and staying above 5% all year. And while full-year earnings growth estimates for S&P500 companies have sunk to zero, consensus forecasts are now pencilling in a rebound of almost 12% next year. Uncertainty about the pace of growth and annual tax receipts in April makes it difficult for government officials to predict the exact "X-date", it said.

Search resuls for: "West Pharma"

12 mentions found